A fixed rule set over this filing's XBRL figures and the number of high-severity risks found in it — no model judgement.
Not investment advice and not a price target: it scores the quarter's fundamentals, not the stock. Full methodology →
AI Takeaway
In Q2 FY2026, Corteva reported net sales of $6.38B (down 1.2% YoY) and net income of $1.16B (down 11.6% YoY) while advancing plans to separate its Seed and Crop Protection businesses and executing cost-reduction initiatives.
Revenue
$6.38B
-1.19% YoY
EPS (Diluted)
$1.73
-9.90% YoY
Corteva (CTVA) reported Q2 FY2026 revenue of $6.38B, down 1.2% year over year. The company posted net income of $1.16B, down 11.6% from a year earlier, with diluted EPS of $1.73. CTVA's fiscal Q2 FY2026 corresponds to calendar Q2 2026.
Corteva's Q2 FY2026 net sales declined 1.2% to $6.38B and net income fell 11.6% to $1.16B, as seed price realization and cost reductions were offset by crop protection price pressure and volume timing shifts.
Last 4 quarters: 3 beats, 1 miss
Adjusted (non-GAAP) EPS of $2.30 versus the $2.27 analyst consensus — a +1.4% beat for Jun 2026. Analyst consensus is quoted on the adjusted (non-GAAP) basis the street uses. GAAP diluted EPS for this quarter was $1.73.
Corteva announced plans to pursue a tax-free spin-off to separate its Seed and Crop Protection businesses into two independent publicly traded companies to optimize operational focus and capital allocation.
Source: 10-Q Item 2 MD&A, p.43
Management approved a restructuring program involving workforce reductions and manufacturing network optimization, including the intended shutdown of its Asturias, Spain facility, targeting $115M to $125M in run-rate cost savings by 2027.
Source: 10-Q Item 2 MD&A, p.43
Seed segment sales held flat at $4.53B with segment operating EBITDA up 6% to $1.97B on strong price and mix performance, whereas Crop Protection sales fell 4% to $1.85B due to Latin America price competition and North America volume timing shifts.
Source: 10-Q Item 2 MD&A, p.48-50
Cost of goods sold decreased 7.3% YoY to $2.72B in Q2 FY2026, driven by ongoing productivity actions, lower net royalty expenses, and reduced overall product volumes.
Source: 10-Q Item 2 MD&A, p.43
Year-to-date operating cash outflow reached -$3.36B compared to -$1.16B in the prior-year period, reflecting heavy working capital requirements inherent to agricultural business seasonality.
Source: 10-Q Cash Flow Statement (XBRL)
Current liabilities grew by 13.4% YoY to $10.79B, raising near-term financial obligations relative to liquid assets.
Source: 10-Q Balance Sheet (XBRL)
Net income declined 11.6% YoY to $1.16B alongside a 1.2% top-line contraction, influenced by Latin America price pressures and geographic volume shifts.
Source: 10-Q Income Statement (XBRL)
This analysis does not extract a guidance section. Companies issue revenue and EPS outlook in the 8-K press release and on the earnings call rather than in the 10-Q itself — though the filing's management discussion can contain forward-looking statements, which appear in the highlights above where they were material.
Corteva (CTVA) is next expected to report on , when the following quarter's results and any updated outlook will be available.
See the CTVA earnings preview — expected date, analyst estimates and what to watch →
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $6.38B | $6.46B | -1.19% |
Cost of Revenue | $2.72B | $2.93B | -7.30% |
Net Income | $1.16B | $1.31B | -11.64% |
EPS (Basic) | $1.73 | $1.92 | -9.90% |
EPS (Diluted) | $1.73 | $1.92 | -9.90% |
R&D Expense | $388M | $375M | +3.47% |
SG&A Expense | $1.16B | $1.16B | +0.69% |
Corteva reported net sales of $6.38B, down 1.2% YoY, and net income of $1.16B, down 11.6% YoY. Strong Seed segment pricing and cost productivity actions partially cushioned lower volumes and competitive price pressure in Crop Protection.
Seed segment sales were flat at $4.53B while Operating EBITDA rose 6% to $1.97B on solid demand for high-technology products. Crop Protection sales declined 4% to $1.85B due to price competition in Latin America, though segment Operating EBITDA rose 2% to $342M on cost savings.
Corteva announced plans for a tax-free separation of its Seed and Crop Protection divisions into two public companies. Additionally, it implemented a restructuring program aiming for $115M to $125M in run-rate savings by 2027 through workforce and site optimizations.
Corteva (CTVA) is next expected to report earnings on Nov 2, 2026. The date comes from the analyst earnings calendar and can shift until the company confirms it.
Expected release date, analyst estimates & what to watch
CTVA delivered strong Q1 FY2026 revenue growth of 11.0% to $4.91B and net income of $720M (+10.4% YoY), though operating cash outflows deepened significantly to -$2.89B, reflecting the seasonal working capital dynamics typical of the agricultural inputs business.
Corteva (CTVA) delivered solid FY2025 results with revenue rising 2.9% to $17.4B, net income surging 20.6% to $1.09B, and operating cash flow jumping 58.8% to $3.4B, reflecting improved cost discipline and stronger profitability.
Other companies in Fertilizers & Agricultural Chemicals